
Treatment according to the DeLOS-II protocol shows survival benefit of patients with locoregional advanced larynx and hypopharynx cancer
Author(s) -
Theresa Wald,
Gunnar Wichmann,
Veit Zebralla,
Andreas Dietz,
Susanne Wiegand
Publication year - 2021
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0041-1727934
Subject(s) - medicine , larynx , laryngectomy , chemotherapy , induction chemotherapy , radiation therapy , cancer , randomized controlled trial , hypopharyngeal cancer , cisplatin , oncology , surgery , head and neck cancer